Clinical Research

March 31, 2021

CheckMate 577 is the first trial to demonstrate the effectiveness of immunotherapy in the adjuvant setting for esophageal cancer or TEG

Although trimodal therapy (neoadjuvant chemoradiation therapy followed by surgery) is the current standard, the risk of relapse is high, especially for 70% to 75% of patients who do not […]